Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consisting of human immunog...
Leadership
Thomas Civik
Interim CEO & Director
Jitendra Wadhane C.A., CPA
Chief Accounting Officer, Senior VP of Finance, Corporate Controller & Principal Financial Officer
Balu N. Balasubramanian Ph.D.
Interim Chief Technology Officer
Alex Kane M.B.A.
Senior Vice President of Investor Relations & Capital Markets
Donna Regalado
Head of Human Resources
Charles T. Gombar Ph.D.
Senior Vice President of Portfolio & Program Management
Michael Bui
Senior Vice President of Global Regulatory Affairs
